Clinical Trial Update: Safety and Explore the Efficacy of Multiple Doses of FURESTEM-AD Inj. for Moderate to Severe Chronic Atopic Dermatitis [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update investigating safety and efficacy of multiple doses of FURESTEM-AD Inj. for moderate to severe atopic dermatitis in Phase 1/2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• FURESTEM-AD Inj.

Snippet

Sponsor: Kang Stem Biotech Co., Ltd. | Conditions: Atopic Dermatitis | Phase 1, Phase 2 | Status: UNKNOWN